DIRECTORS' REPORT CONTINUED
Going Concern continued
As discussed in the Chairman’s
Statement on pages 8 to 10,
the Company announced on
14December2023 that, together with
its advisers, it continues to explore a
number of different initiatives to address
the issues facing the sector and to
secure recognition in the Company’s
share price of the real underlying
value of the Company’s portfolio. On
26February 2024, following the receipt
and review of a number of indications
of interest in a potential combination
of the Company with another listed
investment company by way of section
110 of the Insolvency Act 1986 (“section
110 combination”), the Board instructed
its advisers, Deutsche Numis, to
commence a process of mutual due
diligence with multiple interested
parties. The engagement with parties
interested in a section 110 combination
with the Company is still ongoing and
therefore there can be no certainty that
this process will result in a combination
on terms which the Board considers to
be in the best interests of shareholders
as a whole. Any section 110 combination
would be subject to shareholder
approval.
On 30 May 2023, the Board announced
that shareholders should have a
further opportunity to vote on the
continuation of the Company during
the course of the financial year ending
31 December 2024, expected to be
around September 2024. With the
support of the Company’s brokers, the
Board has consulted with the Company’s
shareholders who have expressed their
high regard for the Investment Adviser
and the Company’s portfolio of assets,
although it is recognised that the
sector as a whole has faced challenges
during recent months as discounts have
widened and liquidity issues persist.
Shareholders have also raised concerns
about the ability for the Company to
grow in the current climate, given the
sustained discount in the share price
versus the NAV. As a result, the Directors
acknowledge that there is uncertainty as
to whether the continuation vote would
pass or fail.
If the continuation vote is not passed,
then according to the Company’s
Articles, the Directors shall within six
months put proposals to shareholders
for the reconstruction, reorganisation or
liquidation of the Company.
Any such proposal would have to take
into consideration the outcome (if any)
of the section 110 process, which was
announced on 26 February 2024. As a
result, the Directors believe that, in the
absence of a section 110 transaction
taking place, the Directors expect that
if the continuation vote is not passed,
formulating and implementing any such
proposals would require the Company
to continue operations for a period
of at least 12 months from the date of
approval of the Company’s financial
statements.
Accordingly, while the Directors
recognise that these conditions indicate
the existence of material uncertainty
which may cast significant doubt about
the Company’s ability to continue as a
going concern, based on the assessment
and considerations above, the Directors
have concluded that the financial
statements of the Company should be
prepared on a going concern basis.
The financial statements do not include
the adjustments that would result if the
Company were unable to continue on
agoing concern basis.
Auditor Information
Each of the Directors, at the date of the
approval of this report, confirms that:
i. so far as the Director is aware, there is
no relevant audit information of which
the Company’s auditors are unaware;
and
ii. the Director has taken all steps
that he/she ought to have taken as
Director to make himself/herself
aware of any relevant information
and to establish that the Company’s
auditors are aware of that
information.
This confirmation is given and should
be interpreted in accordance with
the provisions of section 418 of the
Companies Act 2006.
Annual General Meeting
The following information is
important and requires your
immediate attention. If you are
in any doubt about the action
you should take, you should seek
advice from your stockbroker, bank
manager, solicitor, accountant or
other financial adviser authorised
under the Financial Services and
Markets Act 2000.
The Company’s AGM will be held
on 20 June 2024 at the offices of the
Company’s lawyers, CMS Cameron
McKenna Nabarro Olswang LLP. Full
details of the AGM, the resolutions
proposed and how to vote by proxy are
described in the Notice of Meeting on
pages 116 and 117 of this Annual Report
and the explanatory notes on pages 118
to 120. Shareholders are welcome at any
time to submit questions they may have
to aquilacosecmailbox@apexfs.group.
Resolutions relating to the following
items of special business will be
proposed at the forthcoming AGM to be
held on 20 June 2024.
Resolutions 11, 12, and 13
Authority to Issue Ordinary
Shares and to Disapply
Pre-emption Rights
At the forthcoming AGM, the Board
is seeking to renew the authority
granted to them at the AGM held on
14 June 2023 to allot up to a maximum
of 33.33% of the Company’s shares
in issue as at the date of the Notice of
AGM (equating to 126,028,106 Ordinary
Shares, excluding treasury shares) and
to disapply pre-emption rights when
allotting up to 20.0% of those Ordinary
Shares (equating to 75,624,426 Ordinary
Shares, excluding treasury shares).
The Directors consider that the higher
aggregate authority is in keeping
with recent revised guidance from the
Investment Association in relation to
a UK investment company and the UK
Pre-Emption Group adapted for the
context of an investment company, and
is justified for the reasons set out below.
However, notwithstanding the change
in guidance, the Directors are aware
that the combined authority to disapply
pre-emption rights in respect of up to
20% of the Company’s issued Ordinary
Share capital sought under Resolutions
12 and 13 is high and, accordingly, are
offering shareholders the opportunity
to grant the usual 10% authority
(Resolution 12) with an option to grant
an additional 10% authority, creating an
aggregate 20% authority (Resolution 13).
The Directors believe that a higher 20%
authority is justified to give the Company
flexibility to grow and further expand its
assets, as well as to lower the Company’s
ongoing charges as expenses are
diluted. Ordinary Shares will only be
issued at a price more than the (cum-
income) NAV per existing Ordinary
Share at the time of issue, after costs.
78
Aquila European Renewables Plc|Annual Report 2023